Cresco Labs Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Cresco Labs Inc. (CRLBF) operates as a vertically integrated multistate cannabis company that cultivates, manufactures, and sells retail and medical cannabis products across the United States and internationally; it offers a portfolio of branded products including premium flower, vape pens, live resins, disposable pens, extracts, pre-rolls, concentrates, popcorn, shake, gummies, edibles, tinctures, capsules, salves, and sublingual oils under brands such as Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindys Edibles, Remedi, Sunnyside Chews, and licensed Kiva; the company also runs Sunnyside dispensaries focused on consumer education, trust, and convenience, with wholesale distribution emphasizing national availability. Founded in 2013 and headquartered in Chicago, Illinois, Cresco Labs maintains operations in eight U.S. states targeting both recreational and medical consumers through cultivation, production, and retail channels, while extending into Germany via pharmacy-distributed flower products. In 2025, the company refinanced its senior secured credit facility with a $325 million term loan maturing in 2030 at 12.5% interest to strengthen its balance sheet and support growth, and launched its flagship Cresco-branded flower products in the European Union market through a partnership with Portugal-based Blossom, an EU GMP-certified manufacturer, marking its first international expansion beyond the U.S.
Company News
Cresco Labs to Report Third Quarter 2026 Financial Results on November 6, 2026
Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting
3 Cannabis Stocks to Watch Heading Out of September
Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting
Cresco Labs Appoints Edward Tilly to Board of Directors
Cresco Labs Appoints Edward Tilly to Board of Directors
Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?
Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership
3 Marijuana Stocks For Investors To Consider
Cresco Labs Inc. (CRLBF) Q2 2026 Earnings Call Transcript
Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates
Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
Looking for Cannabis Growth? Watch These 3 Marijuana Stocks in July 2026
Top Cannabis Companies Building Momentum in June 2026
Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank
Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration
Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety